Diet Drug Acomplia Sales Disappoint; No Major Improvement Seen Until 2009
Sales of diet drug Acomplia (rimonabant) , available in Europe but not approved in the U.S., have turned into a major disappointment for Sanofi-Aventis, which says it does not expect the situation to significantly improve until new clinical trial results are ready for submission to regulators in [...]
Roche, GlaxoSmithKline Sign Promotional Agreement for Xenical in U.S.
Pharmaceutical giants Roche and GlaxoSmithKline have signed a promotional agreement for weight-loss medication Xenical (orlistat) in the United States, according to a statement issued April 12th.
The pact gives Glaxo exclusive rights to promote prescription Xenical in the United States. Glaxo also acquired the rights to an over-the-counter (OTC) version of the [...]
Global Sales of Acomplia (Rimonabant, Zimulti) Edge up to $50 Million in 2nd Quarter
Net sales of diet drug Acomplia (Rimonabant, Zimulti) edged up to almost $50 million (32 million Euros) in the second quarter of 2008, according to French pharmaceutical gians Sanofi-aventis.
This marked the strongest quarter for Acomplia (Rimonabant, Zimulti) since its launch two years ago, and was aided [...]
Diet Drug Acomplia Sales Dwarfed by Initial Sales of Diet Pill alli
Just how badly sales of diet drug Acomplia (rimonabant) have been set back by Sanofi’s inability to bring it to the U.S. market was dramatically illustrated July 25th when GlaxoSmithKline revealed initial launch results for over-the-counter diet pill alli (low-dose Xenical).
Sales of non-prescription alli totaled a [...]
Diet Drug Acomplia (Rimonabant, Zimulti) Reaches End of Road
The end of the road for diet drug Acomplia (Rimonabant, Zimulti) was effectively reached on Nov. 5th when French drugmaker Sanofi-Aventis announced it was halting all further research on what it once expected to be the next blockbuster diet pill.
“ It’s over,” Sanofi spokesperson Jean Marc [...]
The L-Marc Research Center (Louisville Metabolic and Atheroscerosis Research Center) in Louisville, Kentucky, is one of the most active metabolic research centers in the world, focusing Acomplia (rimonabant) on Phase II-IV clinical trials of weight-loss drugs.
The clinic is a leading recruiter of participants in weight-loss trials, and [...]
Raids in Europe Crack Ring Selling Counterfeit Acomplia on Internet
Simultaneous police raids conducted on April 24, 25 and 26 involving five European countries resulted “in the dismantling of a network of internet sales of counterfeit pills of the drug Rimonabant (Acomplia) ,” according to Eurojust, the European Union’s Judicial Cooperation Unit.
The investigation, initiated by the public health [...]
Zimulti Acomplia News About Rimonabant Sales of Acomplia Lag, But Sanofi Still Has High Hopes for Rimonabant
With sales of Acomplia (rimonabant) lagging in the several dozen countries where it is on the market, Sanofi-Aventis executives had little to say about their pioneering obesity treatment in a report to analysts on Feb. 12th. But that hardly means they have given up on the CB-1 [...]
